Gabriele Cerrone

Mr. Gabriele M.
Cerrone is a Non-Executive Chairman at OKYO Pharma Ltd., a Non-Executive Chairman at AccuStem Sciences, Inc., an Executive Chairman & Managing Partner at Panetta Partners Ltd., an Executive Chairman at Tiziana Life Sciences Ltd. (Bermuda), an Executive Chairman at Tiziana Life Sciences Ltd. (United Kingdom), a Chairman at Arna Therapeutics Ltd. and a Chairman at Biovitas Capital Ltd. He is on the Board of Directors at Gensignia IP Ltd. Mr. Cerrone was previously employed as a Chairman by Rasna Therapeutics, Inc. /Old/, a Chairman by Synergy Pharmaceuticals LLC, an Independent Director by Inhibitex LLC, a Chairman by FermaVir Pharmaceuticals LLC, a Chairman by Callisto Pharmaceuticals, Inc., a Senior Vice President-Investments by Oppenheimer & Co., Inc., a Managing Director-Investments by Barrington Capital Group LP, an Executive Chairman by Gensignia Life Sciences, Inc., an Executive Chairman by Gensignia Ltd., and a Co-Founder by Hepion Pharmaceuticals, Inc. He also served on the board at SIGA Technologies, Inc., Cardiff Oncology, Inc. and Pawfect Foods, Inc. He received his MBA from The Leonard N Stern School of Business.